kengreal

Generic: cangrelor

Labeler: chiesi usa, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name kengreal
Generic Name cangrelor
Labeler chiesi usa, inc.
Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAVENOUS
Active Ingredients

cangrelor 50 mg/1

Manufacturer
Chiesi USA, Inc.

Identifiers & Regulatory

Product NDC 10122-620
Product ID 10122-620_8c5e6180-c346-48e7-818d-471089de4ee7
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA204958
Listing Expiration 2026-12-31
Marketing Start 2015-07-08

Pharmacologic Class

Established (EPC)
p2y12 platelet inhibitor [epc]
Mechanism of Action
p2y12 receptor antagonists [moa]
Physiologic Effect
decreased platelet aggregation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 10122620
Hyphenated Format 10122-620

Supplemental Identifiers

RxCUI
1656056 1656061
UNII
6AQ1Y404U7
NUI
N0000182142 N0000008832 N0000182143

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name kengreal (source: ndc)
Generic Name cangrelor (source: ndc)
Application Number NDA204958 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 50 mg/1
source: ndc
Packaging
  • 10 VIAL, SINGLE-USE in 1 CARTON (10122-620-10) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE (10122-620-01)
source: ndc

Packages (1)

10122-620-10 10 VIAL, SINGLE-USE in 1 CARTON (10122-620-10) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE (10122-620-01)

Ingredients (1)

cangrelor (50 mg/1)

Linked Drug Pages (1)

KENGREAL ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "8c5e6180-c346-48e7-818d-471089de4ee7", "openfda": {"nui": ["N0000182142", "N0000008832", "N0000182143"], "unii": ["6AQ1Y404U7"], "rxcui": ["1656056", "1656061"], "spl_set_id": ["88b434fa-8891-4fd5-9d86-7ea64667c08f"], "pharm_class_pe": ["Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["P2Y12 Platelet Inhibitor [EPC]"], "pharm_class_moa": ["P2Y12 Receptor Antagonists [MoA]"], "manufacturer_name": ["Chiesi USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, SINGLE-USE in 1 CARTON (10122-620-10)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE (10122-620-01)", "package_ndc": "10122-620-10", "marketing_start_date": "20150708"}], "brand_name": "KENGREAL", "product_id": "10122-620_8c5e6180-c346-48e7-818d-471089de4ee7", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Decreased Platelet Aggregation [PE]", "P2Y12 Platelet Inhibitor [EPC]", "P2Y12 Receptor Antagonists [MoA]"], "product_ndc": "10122-620", "generic_name": "cangrelor", "labeler_name": "Chiesi USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "KENGREAL", "active_ingredients": [{"name": "CANGRELOR", "strength": "50 mg/1"}], "application_number": "NDA204958", "marketing_category": "NDA", "marketing_start_date": "20150708", "listing_expiration_date": "20261231"}